Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss severity relates to increased miniaturization in female pattern hair loss.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

Men with enlarged prostates often have more severe baldness.

Microsurgical reconstruction effectively covers complex scalp defects but doesn't improve survival for cancer-related cases.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Finasteride for hair loss has minimal impact on sexual function.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

Hair loss common in Norwegian men, affecting self-esteem and life quality.

Bimatoprost is safe and effective for improving eyebrow hair.

Custom-designed implants effectively repaired skull damage in most soldiers injured in combat.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Combination therapy improves hair growth in advanced hair loss.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.